Vascular aging
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 35 to 85 years who agree to participate in the study and do not meet any of the exclusion criteria.;Inclusion criteria: Patients aged 35 to 85 years who agree to participate in the study and do not meet any of the exclusion criteria.;Inclusion criteria: Patients aged 35 to 85 years who agree to participate in the study and do not meet any of the exclusion criteria.;Inclusion criteria: Patients aged 35 to 85 years who agree to participate in the study and do not meet any of the exclusion criteria.;Inclusion criteria: Patients aged 35 to 85 years who agree to participate in the study and do not meet any of the exclusion criteria.
Exclusion criteria
Exclusion criteria: Subjects who are in terminal condition, who cannot travel to the health centers to undergo the corresponding examinations, and those who do not wish to sign the informed consent; Subjects with a history of CVD (ischemic heart disease or stroke, peripheral arterial disease or heart failure), diagnosed renal failure in terminal stages (glomerular filtration rate below 30%), chronic inflammatory disease, or acute inflammatory process in the past three months; Patients treated with estrogens, testosterone, or growth hormone.;Exclusion criteria: Subjects who are in terminal condition, who cannot travel to the health centers to undergo the corresponding examinations, and those who do not wish to sign the informed consent; Subjects with a history of CVD (ischemic heart disease or stroke, peripheral arterial disease or heart failure), diagnosed renal failure in terminal stages (glomerular filtration rate below 30%), chronic inflammatory disease, or acute inflammatory process in the past three months; Patients treated with estrogens, testosterone, or growth hormone.;Exclusion criteria: Subjects who are in terminal condition, who cannot travel to the health centers to undergo the corresponding examinations, and those who do not wish to sign the informed consent; Subjects with a history of CVD (ischemic heart disease or stroke, peripheral arterial disease or heart failure), diagnosed renal failure in terminal stages (glomerular filtration rate below 30%), chronic inflammatory disease, or acute inflammatory process in the past three months; Patients treated with estrogens, testosterone, or growth hormone.;Exclusion criteria: Subjects who are in terminal condition, who cannot travel to the health centers to undergo the corresponding examinations, and those who do not wish to sign the informed consent; Subjects with a history of CVD (ischemic heart disease or stroke, peripheral arterial disease or heart failure), diagnosed renal failure in terminal stages (glomerular filtration rate below 30%), chronic inflammatory disease, or acute inflammatory process in the past three months; Patients treated with estrogens, testosterone, or growth hormone.;Exclusion criteria: Subjects who are in terminal condition, who cannot travel to the health centers to undergo the corresponding examinations, and those who do not wish to sign the informed consent; Subjects with a history of CVD (ischemic heart disease or stroke, peripheral arterial disease or heart failure), diagnosed renal failure in terminal stages (glomerular filtration rate below 30%), chronic inflammatory disease, or acute inflammatory process in the past three months; Patients treated with estrogens, testosterone, or growth hormone.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardio-ankle vascular index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Brachial-ankle pulse wave velocity;Ankle-brachial inde;Central augmentation index;Carotid Intima Media Thickness;Evaluation of retinal vessels; | — |
Countries
China
Contacts
Shanghai Jiao Tong University Affiliated Sixth People's Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital